Scandinavian Biopharma Distribution ApS

CVR 44809028 · Private limited company (ApS) · Active · Very high risk

Scandinavian Biopharma Distribution ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry ikke-specialiseret engroshandel med føde-, drikke- og tobaksvarer. Our model estimates a bankruptcy risk of 12.6% over the next 12 months, which is 9.0 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -536k and a net result of DKK -598k. CEO: Pehr Jonas Bengtsson, Björn Magnus Sjöstrand.

Bankruptcy risk for Scandinavian Biopharma Distribution ApS

12.6%
probability of bankruptcy within 12 months
Very high risk

9.0 × the average (1.41%) · higher risk than 98% of active Danish companies

Lowest riskHighest risk

Increases the risk

Qualification / emphasis of matterYes · bankruptcy rate 29.3%3.3×
Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Equity ratio-50%–0% · bankruptcy rate 14.8%1.7×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×

Reduces the risk

Gross profit growth10%–30% · bankruptcy rate 4.5%0.51×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Number of CEOs2 · bankruptcy rate 5.7%0.65×
Auditor's statementAudit · bankruptcy rate 5.8%0.66×
Number of auditors (historical)1 · bankruptcy rate 6.2%0.70×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44809028
Status
Active
Company type
Private limited company (ApS)
Founded
(2 years)
Address
Lautrupsgade 11
2100 København Ø
Municipality
København
Industry
Ikke-specialiseret engroshandel med føde-, drikke- og tobaksvarer (463900)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 40k
Auditor
Grant Thornton, Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 2
Missing annual reportNo
Negative equityYes
Equity ratio-19.8%
Current ratio83%
Moves (last 2 years)1
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address158
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 466kDKK 371k
Net profitDKK -598kDKK 22k
EquityDKK -536kDKK 62k
Total assetsDKK 2.7mDKK 2.7m
CashDKK 522k–
Short-term debtDKK 3.2m–
Tax owedDKK 0–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Grant Thornton, Godkendt Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025133
1 May 2024 – 31 Dec 2024142

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOPehr Jonas BengtssonCurrent
CEOBjörn Magnus SjöstrandCurrent
CEOPeter Andreas Stakemann
Owner (100%)Scandinavian Biopharma Distribution ABCurrent
Owner (100%)ApS KBUS 38 nr.3117
AuditorGrant Thornton, Godkendt RevisionspartnerselskabCurrent
FounderApS KBUS 38 nr.3117Current

The CEOs' other companies

Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt

Address history (2 moves)

Lautrupsgade 11, 2100 København Ø
Stockholmsgade 45, 2100 København Ø
Amaliegade 35, 1., 1256 København K

Former names

Scandinavian Biopharma Distribution ApS – now
ApS KBUS 18 nr. 750 –

Other companies at the same address

Similar companies in København

Questions and answers about Scandinavian Biopharma Distribution ApS

Has Scandinavian Biopharma Distribution ApS gone bankrupt?

No, Scandinavian Biopharma Distribution ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Scandinavian Biopharma Distribution ApS?

Our model estimates a bankruptcy risk of 12.6% over the next 12 months (very high risk), which is 9.0 times the average for Danish companies.

Who is the CEO of Scandinavian Biopharma Distribution ApS?

Pehr Jonas Bengtsson, Björn Magnus Sjöstrand are the CEOs of Scandinavian Biopharma Distribution ApS.

Who is the auditor of Scandinavian Biopharma Distribution ApS?

Scandinavian Biopharma Distribution ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.

When was Scandinavian Biopharma Distribution ApS founded?

Scandinavian Biopharma Distribution ApS was founded on 1 May 2024.

What is the equity of Scandinavian Biopharma Distribution ApS?

Equity was DKK -536k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.